Kazuya Takamochi

A method of high-throughput functional evaluation of <i>EGFR</i> gene variants of unknown significance in cancer

Shinji Kohsaka, Masaaki Nagano, Yoshiyuki Suehara et al. · Science Translational Medicine · 2017 · 212 citations

Medicine, Molecular Biology, Oncology +15

Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma

Aritoshi Hattori, Shunki Hirayama, Takeshi Matsunaga et al. · Journal of Thoracic Oncology · 2018 · 187 citations · Full text

Medicine, Oncology, Surgical Oncology +9

Prognostic impact of a ground-glass opacity component in clinical stage IA non–small cell lung cancer

Aritoshi Hattori, Kenji Suzuki, Kazuya Takamochi et al. · Journal of Thoracic and Cardiovascular Surgery · 2020 · 178 citations · Full text

Medicine, Oncology, Neoplasia +12

EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas

Kazuya Shinmura, Shinji Kageyama, Tomoyasu Bunai et al. · Lung Cancer · 2008 · 163 citations

Life Sciences, Molecular Biology, Oncology +16

Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer

Aritoshi Hattori, Takeshi Matsunaga, Kazuya Takamochi et al. · The Annals of Thoracic Surgery · 2016 · 146 citations · Full text

Medicine, Oncology, Thoracic Oncology +7